INDP – indaptus therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Indaptus Therapeutics (NASDAQ:INDP) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Form SCHEDULE 13G/A Indaptus Therapeutics, Filed by: YA II PN, Ltd.
Form 8-K Indaptus Therapeutics, For: Mar 31
Form 3 Indaptus Therapeutics, For: Mar 23 Filed by: Yao Yun
Form 3 Indaptus Therapeutics, For: Mar 23 Filed by: SINO LION VENTURES Ltd
Form 3 Indaptus Therapeutics, For: Mar 23 Filed by: Dai Junyi
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.